LGALS3BP and hemophagocytic syndrome: The four markers with upregulated expression (CRP, LGALS3BP, HSPA8, and MSN) are basically related to the immune dysregulation, and related inhibitors could be developed or used to inhibit the expression of these molecules, so as to promote the early anti-inflammatory and immune-modulating therapy for EBV-HLH.